With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA. | With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.

His tenure was marked by organizational upheaval, controversies over drug approvals and tensions with the White House.

Marty Makary is resigning after just over a year leading the powerful health regulatory agency.